Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab

Berkovich, Regina MD, PhD Inc. · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
multiple-sclerosis
multiple sclerosis, multiple sclerosis, relapsing-remitting, natalizumab, drug holiday, alternative dosing, extended dosing, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 898484
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.